HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Flavone acetic acid potentiates the induction of endothelial procoagulant activity by tumour necrosis factor.

Abstract
Treatment of human umbilical vein endothelial cells with flavone acetic acid (FAA) at 800 micrograms/ml for 4 h resulted in a 3-11-fold increase in procoagulant activity. This increase was due to enhanced tissue factor expression on the endothelial cell surface, as evidenced by the blocking of the enhanced clotting with antibody to tissue factor, by substitution of normal with factor VII deficient plasma, or by simultaneous treatment of the endothelial cells with cycloheximide or actinomycin D. FAA was not toxic to endothelial cell at concentrations up to 1.6 mg/ml over 4 h. Combined treatment with FAA and tumour necrosis factor alpha (TNF-alpha) (100 pg/ml) produced a 675-fold (range 160-1980) increase in tissue factor activity, compared to 5-fold and 50-fold increases for the individual agents respectively. Northern blotting of total RNA from cells treated with the combination of agents or either agent alone, followed by probing with a cDNA to human tissue factor demonstrated a synergistic increase in tissue factor mRNA after combination treatment. In vivo, the combination of FAA and TNF-alpha could be shown to induce greater growth delay in two murine tumours than would be predicted on the basis of the activity of either agent alone.
AuthorsJ C Murray, K A Smith, D M Stern
JournalEuropean journal of cancer (Oxford, England : 1990) (Eur J Cancer) Vol. 27 Issue 6 Pg. 765-70 ( 1991) ISSN: 0959-8049 [Print] England
PMID1829921 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Flavonoids
  • Tumor Necrosis Factor-alpha
  • flavone acetic acid
  • Thromboplastin
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Blotting, Northern
  • Cells, Cultured
  • Drug Synergism
  • Endothelium, Vascular (drug effects)
  • Flavonoids (pharmacology)
  • Humans
  • Male
  • Mice
  • Mice, Inbred CBA
  • Neoplasms, Experimental (drug therapy)
  • Thromboplastin (metabolism)
  • Tumor Necrosis Factor-alpha (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: